Search

Author/Creator Lundin, Jeanette

1. Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study. (November 2022)

Authors:
Ma, Shuo; Rosen, Steven T.; Winqvist, Maria; Frankfurt, Olga; Winter, Jane N.; Gordon, Leo; Helenowski, Irene; Zhang, Hui; Kreutzer, Jennifer; Sönnert-Husa, Sonja; Österborg, Anders; Lundin, Jeanette
Journal:
Leukemia research
Issue:
Volume 122(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Dual targeting of Bruton tyrosine kinase and CD52 induces minimal residual disease‐negativity in the bone marrow of poor‐prognosis chronic lymphocytic leukaemia patients but is associated with opportunistic infections – Results from a phase I study. (5th July 2017)

Authors:
Winqvist, Maria; Palma, Marzia; Heimersson, Kia; Mellstedt, Håkan; Österborg, Anders; Lundin, Jeanette
Journal:
British journal of haematology
Issue:
Volume 182:Number 4(2018)
Page Start:
590
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ibrutinib induces rapid down‐regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia‐related genes in blood and lymph nodes. (20th August 2018)

Authors:
Palma, Marzia; Krstic, Aleksandra; Peña Perez, Lucia; Berglöf, Anna; Meinke, Stephan; Wang, Qing; Blomberg, K. Emelie M.; Kamali‐Moghaddam, Masood; Shen, Qiujin; Jaremko, Georg; Lundin, Jeanette; De Paepe, Ayla; Höglund, Petter; Kimby, Eva; Österborg, Anders; Månsson, Robert; Smith, C. I. Edvard
Journal:
British journal of haematology
Issue:
Volume 183:Number 2(2018)
Page Start:
212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Risk‐adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real‐world report on 141 consecutive Swedish patients. (10th August 2020)

Authors:
Mattsson, Agnes; Sylvan, Sandra E.; Asklid, Anna; Wiggh, Joel; Winqvist, Maria; Lundin, Jeanette; Mansouri, Larry; Rosenquist, Richard; Johansson, Hemming; Österborg, Anders; Hansson, Lotta
Journal:
British journal of haematology
Issue:
Volume 191:Number 3(2020)
Page Start:
426
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Temporary cessation of ibrutinib results in reduced grade 3‐4 infections and durable remissions—Interim analysis of an on‐off‐repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia. Issue 3 (14th July 2021)

Authors:
Lundin, Jeanette; Mulder, Tom A.; Kättström, Magdalena; Wästerlid, Tove; Uddevik, Anders; Mellstedt, Håkan; Heimersson, Kia; Hansson, Lotta; Palma, Marzia; Österborg, Anders
Journal:
EJHaem
Issue:
Volume 2:Issue 3(2021)
Page Start:
525
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗